Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.62 0.14 (3.12%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 283.66(M)
Last Volume: 821,939 Avg Vol: 693,736
52 Week Range: $3.38 - $6.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 549
  Page 4 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mitchell Stephen Ray Director   –       •      –    2021-09-09 4 OE $10.57 $229,936 D/D 19,109 28,324     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2021-08-20 4 S $15.39 $56,190 D/D (3,650) 74,552 1%     
   Williams Timothy SVP & General Counsel   •       –      –    2021-08-16 4 S $16.15 $59,989 D/D (3,715) 83,211 -6%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2021-07-28 4 S $19.24 $40,973 D/D (2,130) 99,296 18%     
   Jones Aranthan Ii Chief Corp. Affairs Officer   •       –      –    2021-07-26 4 S $19.69 $142,776 D/D (7,250) 86,685 19%     
   Mitchell Stephen Ray Director   –       •      –    2021-06-15 4 S $19.42 $97,122 D/D (5,000) 9,215 7%     
   Mitchell Stephen Ray Director   –       •      –    2021-06-15 4 OE $10.57 $42,439 D/D 4,015 14,215     -
   Chrousos Phaedra Director   –       •      –    2021-06-14 4 S $19.34 $40,132 D/D (2,075) 12,925 8%     
   Watkins Thomas Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 5,000 54,505     -
   Chrousos Phaedra Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 5,000 15,000     -
   Mitchell Stephen Ray Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 5,000 10,200     -
   Ward Anne Sempowski Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 5,000 10,000     -
   Dugan Richard W Director   –       •      –    2021-06-10 4 A $0.00 $0 D/D 5,000 59,887     -
   Jones Aranthan Ii Chief Corp. Affairs Officer   •       –      –    2021-03-15 4 S $17.72 $319,010 D/D (18,000) 93,935 -11%     
   Jones Aranthan Ii Chief Corp. Affairs Officer   •       –      –    2021-03-15 4 OE $11.32 $169,800 D/D 15,000 111,935     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2021-03-08 4 S $18.00 $3,150,053 D/D (175,000) 1,221,062 -6%     
   Williams Timothy SVP & General Counsel   •       –      –    2021-03-05 4 S $17.85 $99,966 D/D (5,600) 86,926 -6%     
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2021-03-02 4 S $18.34 $278,902 D/D (15,206) 1,396,062 -11%     
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2021-03-02 4 S $18.45 $71,729 D/D (3,888) 78,202 -11%     
   Jones Aranthan Ii Chief Corp. Affairs Officer   •       –      –    2021-03-02 4 S $18.04 $69,717 D/D (3,865) 96,935 -11%     
   Williams Timothy SVP & General Counsel   •       –      –    2021-03-02 4 S $18.54 $142,307 D/D (7,674) 92,526 -11%     
   Birznieks Gunther SVP, Business Development   •       –      –    2021-03-02 4 S $18.19 $302,273 D/D (16,620) 171,708 -11%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2021-03-02 4 S $18.23 $110,191 D/D (6,044) 101,426 -11%     
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2021-03-01 4 S $18.45 $138,003 D/D (7,479) 1,411,268 -10%     
   Williams Timothy SVP & General Counsel   •       –      –    2021-03-01 4 S $18.60 $220,543 D/D (11,856) 100,200 -10%     
  549 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us